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Abstract 
Conditioned medium (CM) derived from human umbilical cord mesenchymal stem cell culture has been studied 
in Type 1 Diabetes Mellitus (T1DM) and showed a good prospect as an alternative treatment. However, effects 
of CM in Type 2 Diabetes Mellitus (T2DM) have not been studied. The purpose of this study was to investigate 
the ability of human umbilical cord mesenchymal stem cell-derived conditioned medium (CM) for the recovery 
of pancreatic β-cells in T2DM-induced Wistar Rats (Rattus norvegicus). The T2DM-induced rats were prepared 
by applying combination injection of nicotinamide (NA) and streptozotocin (STZ). The T2DM-induced rats were 
treated with 0.2 ml CM fourth times periodically, with a week interval. One week after each CM treatment, the 
pancreas glands were collect, fixed in Bouin’s solution, processed by paraffin method and carried out 
immunohistochemistry staining for insulin detection. The blood samples were collected for glucose 
concentration evaluation. Microscopic observation indicated the decrease of immunoreactive cell number and its 
intensity towards insulin after the combination injection of NA and STZ. One week after first and second CM 
treatment, the presence of numerous and hight intensity of insulin- immunoreactive (IR) cells in the pancreatic 
islets could be observed. However, the number of insulin-IR cells and its intensity decreased dramatically 1 week 
after the third CM treatment and almost disappeared in 1 week after the fourth CM treatment in all of the 
pancreatic islets. The histological features changes of insulin-IR cells are in agreement with the profile dynamics 
of glucose concentration in the blood. This study showed that conditioned medium (CM) derived from human 
umbilical cord mesenchymal stem cell culture has ability to recover the insulin production from pancreatic β-
cells in T2DM-induced Wistar rats (Rattus norvegicus) temporary. 
Keywords: conditioned medium, type 2 diabetes mellitus, pancreatic β-cells, temporal recovery, nicotinamide-
streptozotocin 
 
1. Introduction 
Type 2 Diabetes Mellitus (T2DM) occurs due to insufficient insulin production from β-cells within the setting of 
insulin resistance (David & Dolres 2011). Insulin resistance is the inability of cells to respond adequately to 
normal levels of insulin (Tfayli & Arslanian 2009). In the liver, insulin normally suppresses glucose release. 
However, in the setting of insulin resistance, the liver inappropriately releases glucose into the blood (Szkudelski 
et al. 1998). The proportion of insulin resistance and β-cell dysfunction differs among individuals, with some 
having primarily insulin resistance and only a minor defect in insulin secretion and others with slight insulin 
resistance and primarily a lack of insulin secretion (David & Dolres 2011). 
The number of people affected by T2DM is approximately 90% compared with 10% of Type 1 Diabetes 
Mellitus (T1DM) (Chabot 2002). International Diabetic Federation declared that there were 387 million diabetics 
worldwide and Indonesia was in seventh position. Type 2 Diabetes Mellitus (T2DM) often can treated by losing 
weight and exercising more, as these increases the body’s sensitivity to insulin. Metformin drug, that works by 
helping the fat and muscle cells of the body listen to the signal from insulin to take up sugar from the blood, 
often given to diabetic. Insulin treatment may either, be added to oral medication or used alone (Ripsin et al. 
2009). Latest study reported that conditioned medium derived from human umbilical cord mesenchymal stem 
cell can regenerate the pancreatic β-cells damage in T1DM-induced Wistar rats (Rattus norvegicus), both in 
structure and function (Kitada et al. 2003). 
Stem cells have ability to supply trophic factors which may regenerate damaged tissues (Yang et al. 2013). 
Moreover, some studies on stem cell-derived secreted factors indicated that the secreted factors alone without the 
stem cell will repair tissue in varied conditions involving damaged tissue or organ (Timmers et al. 2011; Mishra 
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& Banarjee 2012; Hynes et al. 2013). The secreted factors often detected exceedingly in the medium where the 
stem cells are cultured, therefore referred to as conditioned medium or CM (Kim & Choi 2013). Various study 
reported that conditioned medium contains varied growth factors, interleukin and others regenerative agents 
(White et al. 2008; Sze et al. 2007).  
There is advantage on the utilization of CM compared to the stem cells. Since there is no cell in CM, the 
rejection problem by recipient to the donor does not exist. Therefore, the conditioned medium features a 
promising prospect as alternative treatment in regenerative disease (Pawitan 2014). The evidence of potency CM 
as regenerative agent in T2DM is necessary. This study were carried out to investigate the ability of human 
umbilical cord-mesenchymal stem cell-derived conditioned medium for the recovery of pancreatic β-cells in 
T2DM induced Wistar Rats (Rattus norvegicus). 
 
2. Materials and Methods 
This study was approved by Ethical Clearence Committee from Universitas Gadjah Mada. Fifty four male 
Wistar rats (Rattus norvegicus), weight 150-250 gram, were used in this study. The rats were divided into 3 
groups: group I (normal control group), group II (diabetic group), and group III (CM-treated diabetic group). 
Type 2 Diabetes Mellitus in rats were achieved by single injection nicotinamide (NA) dose 230 mg/BW and 
streptozotocin (STZ) dose 65 mg/BW intraperitoneally (Ghasemi et al. 2014).  
Conditioned Medium (CM) was obtained from the culture medium of human umbilical cord mesenchymal 
stem cells at the third passage. Group II and III were injected with single dose NA and STZ at same time. In the 
fifth days post injection of NA and STZ, group III were treated with 0.2 ml CM by intramuscular injection. The 
CM treatment was repeated 4 times with interval a week. Group I as control normal group were not received any 
treatment. One day post adaptation, five days after NA-STZ injection, and one week after each CM treatment, 
the blood samples were collected from all groups for evaluation. Glucose concentration was measured using 
GlucoDr® (All Medicus Co., Ltd). At the same time, four rats sample were euthanized, pancreas glands were 
collected, and fixed in Bouin’s solution for 24 hours. The pancreatic tissues were processed with paraffin method 
and cut serially in 5 µm thickness. One slide of pancreatic tissue in every samples were used to detect the 
immunolocalization of insulin in the pancreatic islets using N-Histofine®simple stain rat MAX PO Kit (Cosmo 
Bio, Ltd). 
 
3. Results 
Photomicrograph showed reduction on the number and intensity of insulin-IR cells (Fig.1B) in the pancreatic 
islets after single dose injection of streptozotocin and nicotinamide compared with the number and intensity of 
insulin-IR cells in the pancreatic islets of normal rats (Fig. 1A). One week after first CM treatment, the number 
and intensity of insulin-IR cells were increased excessively (Fig. 1C). Insulin-IR cells still could be detected  
constantly one week after second CM treatment (Fig. 1D). In contrast, the number and intensity of insulin-IR 
cells dramatically decreased in one week after third CM treatment (Fig. 1E) and almost could not be detected 
after fourth CM treatment (Fig. 1F) in all pancreatic islets. 
The histological changes (Fig. 1) on the number and intensity of insulin-IR cells in pancreatic islets were in 
agreement with dynamics of glucose concentration (Table 1). Five days post NA-STZ injection, diabetes 
mellitus has been achieved as indicated by high level of glucose concentration, 319.50 mmol/L in group III and 
270.50 mmol/L in group II compared to 113.21 mmol/L in normal control group (group I). The glucose 
concentration of diabetic rat was in high level continuously and tendency to increase (428.67 mmol/L) in the end 
of treatment. In CM-treated diabetic group, the glucose concentration was decrease one week post first CM 
treatment from 319.5 to 132 mmol/L. There were dynamics of glucose concentration level in CM-treated 
diabetic group, although it still lower almost a half than glucose concentration level of diabetic group, but still 
higher than glucose concentration level of normal control group. 
Table 1. Average glucose concentration (mmol/l) in group I, group II, and group III. 
   Groups 
Days of treatment 
1 day Post 
adaptation 
5 days post 
NA-STZ 
treatment 
1 week 
post 
treatment 1 
1 week 
post 
treatment 2 
1 week 
post 
treatment 3 
1 week 
post 
treatment 4 
   Group I 91,60 113,21 85,1 113,25 113,17 120,33 
   Group II 77,00 270,50 240,27 271,78 335,17 428,67 
   Group III 90,80 319,50 132 140,9 120 152,00 
*NA= nicotinamid,  STZ= streptozotocyn, Group I= normal control group, Group II= diabetic group, Group III= 
CM-treated diabetic group. 
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4. Discussion 
Insulin-IR cells are identified as β-cell in pancreatic islets (Budipitojo et al. 2016). The present studies showed 
decreasing of the insulin-IR cells number in the pancreatic islets after single dose injection of nicotinamide (NA) 
and streptozotocin (STZ) intraperitoneally, although some pancreatic β-cells were still detected with very light 
insulin immunoreactivity. Insufficient of insulin production from pancreatic β-cell will make glucose can not be 
used effectively by the other cells (David & Dolores 2011). Such condition refers to diabetes mellitus, as 
indicated by high glucose concentration in blood stream, same as our finding in this research. Injections of 
nicotinamide and streptozotocin have been used widely to generate Type 2 Diabetes Mellitus (T2DM) in other 
species, such as rabbit, dog, monkey, and cat (Goldner & Gomori 1944). Single dose injection of NA-STZ will 
lead to fast pancreatic β-cell death (Saini 2010).  
Conditioned Medium derived from human umbilical cord mesenchymal stem cell has been tried in Type 1 
Diabetes Mellitus (T1DM)-induced rat. The result showed a good prospect as alternative therapy for diabetic. 
Conditioned Medium treatment in T1DM-induced rat not only regenerate pancreatic β cell but also maintain 
their function to produce insulin (Nugroho et al. 2016). Latest result showed CM treatment in T2DM-induced rat 
has different effect. Treatment could regenerate pancreatic β-cell after first and second administration but it 
progressively decrease again in third and fourth administration. However, insulin production still could 
maintenance glucose concentration lower than diabetic rat and almost same with normal rat. The dose and how 
long CM treatment should be given in T2DM patient still need to investigate furthermore. 
 
Figure 1. Immonolocalization profile of insulin immunoreactive cells in pancreatic islets. 
Numerous and stronger intensity of insulin-immunoreactive (IR) cells were detected 
in the pancreatic islets of normal control group (Fig. 1A) compared with diabetic 
group (Fig. 1B) as indicated by arrows. The presence of abundance insulin-IR cells 
with strong intensity were detected one week after the first CM treatment in the 
pancreatic islets (Fig. 1C). The number and intensity of insulin immunoreactive cells 
were detected constantly until one week after second CM treatment (Fig. 1D). The 
number of insulin-IR cells and the intensity decreased dramatically one week after 
third CM treatment (Fig. 1E) and almost dissapeared after the fourth CM treatment 
(Fig. 1E), in all the pancreatic islets. Stars indicated non β cells or β cells with no 
insulin immunoreactivities in the pancreatic islets 
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Some proteomic study reported that various growth factor and cytokine presented in the CM (Pawitan 2014). 
In present study, CM could regenerate pancreatic β-cell and restore their function to produce insulin in early CM 
treatment. Type 2 diabetes mellitus (T2DM) were characterized with pancreatic β-cell dysfunction or insulin 
insensitivity on target cells (Saiedullah 2016). Inflammatory cytokines may play a role in pancreatic β-cell 
dysfunction and insulin resistance in type 2 diabetes mellitus.  Tumor necrosis factor-α (TNF-α) is an 
inflammatory cytokine found in CM (Pawitan 2014) and naturally secreted by macrophages, lymphocytes and 
also adipocytes. TNF-α could be a promising treatment of T2DM before progression of pancreatic β-cell 
dysfunction. There were correlation between TNF-α with percentage of pancreatic β-cell function and insulin. It 
may indicate pancreatic β-cell compensated to insulin resistance produced by TNF-α in peripheral tissue 
(Swaroop et al. 2012).  
Growth factors and cytokines level released in CM depend on cell type, cell number, medium condition and 
culture process. Tumor necrosis factor-α (TNF-α) level in umbilical cord mesenchymal stem cell CM have not 
been known yet, so it has to investigate furthermore. Administration of anti TNF-α in T1DM and T2DM mice 
might recover pancreatic β-cell and insulin-IR cells (Koulmanda et al. 2012).  Furthermore, production 
conditioned medium should be adjusted as a new candidate for DM treatment. Cell type, cell number, medium 
condition and culture process for DM treatment should be treated as needed to reduce inflammatory cytokines 
released in CM. In this present study, insulin IR-cells on pancreatic islet were decrease progressively after third 
and fourth CM administration. Inflammatory cytokines (Donath et al. 2003) and oxidative stress (Kaneto et al. 
2006) associated with pancreatic β-cell apoptosis and reduce their ability to produce insulin (Rhodes 2005; Lin 
&Sun 2010). High level of cytokines, such as TNF-α, interlukin-6 (IL-6) and IL-10 (Pawitan 2014) have a role 
in pancreatic β-cell apoptosis in the late CM treatment. Beside, high serum TNF-α level associated with insulin 
insensitivity in T2DM progression.  High serum TNF-α were secreted by macrophages and lymphocytes, 
indicated T2DM represent a chronic inflammation (Miyazaki et al., 2003). Inflammation could increased 
reactive oxygen species (ROS). Several study reported that this oxidative stress markers supported insulin 
insensitivity in T2DM (Lin et al. 2005). However, temporal insulin production induce by CM could maintain 
blood glucose concentration in T2DM. 
Nowadays, some cell types, such as stem cell, endocrine progenitor, others mature cells in the pancreas 
gland, and pancreatic β-cell itself have been developed to generate the pancreatic β cell (Borowiak & Melton 
2009). In addition, there are possibilities of generate pancreatic β-cell from duct-lining and acinar cells (Bonner-
Weir & Weir 2005), or hepatocyte (Porat & Dor 2007). However, it remains unclear which cell type can generate 
to pancreatic β-cell successfully in clinical administration. It needs more effort to develop an applicable diabetic 
therapy from cell line, since CM treatment have a good prospect and more easily administered. Diabetic 
therapies in the future may combine the role of microenvironment factor that suitable for pancreatic β-cell 
development and cell line (Alismail & Jin 2014). Conditioned Medium derived from human umbilical cord 
mesenchymal stem cell may contain signal molecules and biomaterials that suitable for pancreatic β-cell 
development. 
 
5. Conclusion 
The results of present study showed very strong evidence that conditioned medium derived from human 
umbilical cord mesenchymal stem cell could recover the insulin production from pancreatic β-cells in early 
administrated. However, after long treatment the insulin-immunoreactive cells dramatically decreased and 
almost could not be detected in pancreatic islets. 
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